From the NIH – Biotechnology Landscape 2020

Last week I spoke to the NIH biotechnology business leadership in Bethesda, Maryland. To the standing room only crowd, I laid out the challenges that we face over the next decade – the rising cost of new drug development, the increasingly poor odds … Continue reading at ComplianceZen.com →